Dawn Health Secures €11.5 Million to Scale Platform & Product Suite for Next-Gen Pharma Digital Health Solutions
The investment is aimed at supporting the company’s strategy to deliver its platform and product suite to global pharma companies through a SaaS model, while continuing to invest in further offerings within the Dawn Product Suite.
RAKEZ Receives Silver Award at MECHF 2025 for Excellence In Facility Management and Sustainability
Selected from more than 220 entries, RAKEZ stood out for its innovative and environmentally responsible approach to facilities management.
Seegene’s CURECA(TM) Emerges as a Potential Game Changer in End-to-End PCR Automation

With a fully modular design, CURECA introduces a bold vision for automating pre-treatment across diverse PCR specimen types
VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program
Partnership Combines VERAXA’s Proprietary ADC Technology with OmniAb’s Antibody Discovery Technology for Novel Therapies Targeting Solid Tumors.
Nanobiotix Announces Full Results From Completed Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Pancreatic Cancer
Results demonstrated favorable safety, injection feasibility, and encouraging oncologic outcomes in patients (n=22) with locally advanced or borderline resectable pancreatic cancer.
What Are the Symptoms and Causes of Acid Reflux (GERD)?

A healthy outside starts from the inside. Taking care of your digestive health today lays the foundation for a stronger tomorrow.
Unlocking Drug Delivery to the Brain: Phase 3 Pivotal Trial Uses Ultrasound to Break Through the Blood-Brain Barrier | By: Michael Canney, Ph.D., is Chief Scientific Officer at Carthera

Imagine what modern medicine would be like without the ability to effectively and consistently administer drugs intravenously. That’s a good way to frame the huge delivery limitation that plagues neuroscience: Despite all the advances in drug discovery over the past decades, the biggest roadblock to treating brain cancers and other neurological diseases and disorders remains the brain’s own protective shield, the blood-brain barrier. Read on.
Lipoma Removal: Procedure, Recovery And Aftercare Tips For Patients

Lipomas are benign tumors that develop from fatty tissue. Although they are usually harmless, lipomas can cause discomfort or be unsightly, leading some patients to seek surgical removal. In this article, we will discuss the procedure for lipoma removal, as well as recovery and aftercare tips for patients. Surgical removal is the most common method […]
8 Reasons To Consider Disability Support Work

Everyone had different aspirations while growing up as to careers they’d like to pursue. However, these job preferences, over time, do change because you might later realize that a job isn’t fulfilling despite being financially rewarding. If you’re experiencing this, then a career as a disability support worker might be the perfect career path for […]
Sun Nuclear Acquires Oncospace, AI-Focused Radiation Oncology Software Provider
This strategic move underscores the Sun Nuclear commitment to leverage cutting-edge technology to improve treatment outcomes on behalf of their customers.
Dalen Meeter Joins Aspen Neuroscience as Chief Financial Officer

With more than two decades of finance and accounting expertise, Dalen brings extensive experience in scaling private and public companies to his new role.
ZEISS Launches AI-Driven Research Data Platform for Eye Care

“The future of healthcare is in the data. At ZEISS, we are delivering digital innovation to help shape the future of ophthalmology, investing in research methods that empower clinicians and researchers in balancing their clinical care and research requirements,” says Euan S. Thomson, Ph.D., Head of the Digital Business Unit for ZEISS Medical Technology. “The introduction of the ZEISS RDP reflects our commitment to advancing ophthalmic care through smarter, AI-powered tools.”